1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Carlos Wambier: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Tildrakizumab on Epigenetic Age TILDRAKIZUMAB - Psoriasis, Aging | Phase 4 | Completed | Carlos Wambier | 30 | 2022-04-08 | 2024-07-18 |
Dermatitis (1) · Psoriasis (1)
World Health Organization (1) · tildrakizumab (1)
United States (1)